InvesTrust purchased a new position in shares of MetLife, Inc. (NYSE:MET – Free Report) in the fourth quarter, HoldingsChannel.com reports. The firm purchased 94,083 shares of the financial services provider’s stock, valued at approximately $7,691,000. MetLife comprises 2.1% of InvesTrust’s portfolio, making the stock its 15th biggest holding.
Several other hedge funds have also recently made changes to their positions in the business. MeadowBrook Investment Advisors LLC increased its holdings in MetLife by 244.4% in the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 220 shares in the last quarter. Carmichael Hill & Associates Inc. grew its holdings in MetLife by 131.9% in the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 186 shares during the period. Wolff Wiese Magana LLC increased its position in MetLife by 374.3% in the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock valued at $29,000 after buying an additional 277 shares in the last quarter. Peterson Financial Group Inc. bought a new position in shares of MetLife in the third quarter valued at approximately $30,000. Finally, Fortitude Family Office LLC raised its position in MetLife by 177.3% in the 3rd quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock valued at $34,000 after buying an additional 266 shares during the last quarter. 94.99% of the stock is owned by institutional investors.
MetLife Price Performance
Shares of MET stock traded up $0.52 during trading on Wednesday, hitting $82.66. The company had a trading volume of 2,193,317 shares, compared to its average volume of 2,563,641. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51. MetLife, Inc. has a 52 week low of $64.61 and a 52 week high of $89.05. The stock has a market capitalization of $57.24 billion, a price-to-earnings ratio of 16.67, a price-to-earnings-growth ratio of 0.76 and a beta of 1.07. The stock’s 50-day moving average is $82.85 and its two-hundred day moving average is $78.81.
MetLife Dividend Announcement
Analysts Set New Price Targets
Several research firms have recently issued reports on MET. Barclays upped their target price on shares of MetLife from $90.00 to $96.00 and gave the stock an “overweight” rating in a research note on Monday. TD Cowen lifted their target price on shares of MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a research report on Wednesday, November 27th. Piper Sandler increased their price target on MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a research report on Wednesday, October 2nd. StockNews.com upgraded shares of MetLife from a “hold” rating to a “buy” rating in a research report on Wednesday, January 1st. Finally, JPMorgan Chase & Co. increased their price objective on MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a report on Tuesday. Fourteen analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $89.23.
Get Our Latest Stock Report on MET
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
- Five stocks we like better than MetLife
- What is the NASDAQ Stock Exchange?
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- The Role Economic Reports Play in a Successful Investment Strategy
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- What is the Dow Jones Industrial Average (DJIA)?
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.